QT Imaging Holdings, Inc. is seeking regulatory authorization for market entry while trading on the Nasdaq stock exchange and conducting clinical studies with Mayo Clinic.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
QT Imaging Holdings, Inc. is seeking regulatory authorization for market entry while trading on the Nasdaq stock exchange and conducting clinical studies with Mayo Clinic.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
Mayo Clinic
medical practice and medical research group based in Rochester, Minnesota, United States
Related events
- Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.
- Veri MedTech is seeking a debut on the Nasdaq exchange and is currently undergoing review by the SEC.
- Korro Bio, Inc. and Wellgistics Health were listed on the Nasdaq stock exchange on July 1, 2026.
- Elutia is trading on the Nasdaq stock exchange and requires regulatory clearance from the FDA for product launches.
- Capricor Therapeutics is seeking regulatory approval from the FDA for clinical trials and has listed on the Nasdaq stock exchange, with a law firm based in New York City involved.